Danone to take over Medical Nutrition USA
By New Statesman - 14 June 13:39

Nutrition supplement company will be folded into the French food group's advanced medical nutrition

Orchid to take over Karalex Pharma
By New Statesman - 11 June 11:59

Orchid, an India-based company, creates this way its presence in the front-end US market.

Endo Pharma, Penwest settle Opana ER patent litigation with Sandoz
By New Statesman - 10 June 12:27

Sandoz will have a licence to sell a generic version of the drug from September 2012.

TKL Research takes equity position in CRO Proinnovera to expand in Europe
By New Statesman - 10 June 12:25

The US-based clinical research company expands its position in Europe with equity position in German

Astellas acquires medical biotechnology company OSI Pharma
By New Statesman - 10 June 12:22

OSI is expected to augment Astellas's current focus on urology and transplantation.

Pfizer and Epocrates to collaborate on access to clinical information
By New Statesman - 04 June 12:04

New strategy for healthcare providers will include a drug reference app for the iPhone.

Novella Clinical takes over Prologue Research
By New Statesman - 04 June 12:00

Novella acquires the Ohio-based clinical research organisation which specialises in oncology drugs.

Pharma firms are increasingly seeking to outsource manufacturing
By New Statesman - 04 June 11:57

Move is part of an effort to keep costs down, according to a new report.

Another Danish drug maker withdraws products from Greece
By New Statesman - 02 June 13:21

Danish group Leo Pharma suspends Greek sales following government austerity measures.

Orexo, OMJ forge alliance to develop new drugs for respiratory diseases
By New Statesman - 02 June 11:57

Agreement will initially run for three years, after which OMJ has option to extend the alliance.

Sanofi-aventis, Charite ink R&D agreement
By New Statesman - 02 June 11:52

CEO of Sanofi-aventis: "We are very pleased to collaborate with the Charité, one of Europe's top-cla

Amgen Prolia gets marketing authorization in EU
By New Statesman - 31 May 13:39

Amgen said that the European Commission (EC) has granted marketing authorization for Prolia (denosum

Abbott Biotech ventures joins Alvine investor lineup
By New Statesman - 31 May 13:30

Alvine Pharmaceuticals, a privately held clinical stage biopharmaceutical company focused on develop

Valeant acquires Aton Pharma
By New Statesman - 31 May 13:22

Valeant Pharmaceuticals International has acquired Lawrenceville, New Jersey-based Aton Pharma, a sp

Spire hospitals to be sold before IPO
By New Statesman - 24 May 14:51

Public offering of £1bn planned.

Pfizer to cut 6,000 jobs globally
By New Statesman - 19 May 14:14

The company took over major rival Wyeth last October, for $67bn.

ProKarma enters into merger agreement with abc Consulting
By New Statesman - 18 May 11:33

Technology solutions firm seeks merger in order to expand into Latin America.

Beximco Pharma posts first quarter results
By New Statesman - 17 May 11:09

The company has posted a net profit of $0.21m for the first quarter 2010.

China Medicine first quarter revenues surge 4.7 per cent
By New Statesman - 17 May 11:06

China Medicine has announced a net income of $1.79m for the first quarter of 2010.

Atypical antipsychotics off-label use increases diabetes risk among elderly: new study
By New Statesman - 14 May 11:07

Atypical antipsychotics are used for treating schizophrenia, bipolar mania and acute mania and are s

NicOx updates on Naproxcinod FDA approval
By New Statesman - 14 May 11:02

The recommendation was based on a data review from a program which included 35 clinical studies on m

Cell Therapeutics signs agreement with NCCTG for Pixantrone Phase II study
By New Statesman - 14 May 10:55

Two different dosing schedules of Pixantrone will be tested.

GSK agrees to pay $60m in Avandia lawsuits
By New Statesman - 13 May 11:07

Settlement expected to resolve more than 700 lawsuits.

Bioject Medical reports first quarter results
By New Statesman - 13 May 11:02

Revenues of $1.2m compared to $2m reported in the comparable year-ago quarter.

Abbott collaborates with Zydus Cadila
By New Statesman - 12 May 11:54

Abbott expected to gain rights to at least 24 Zydus products.

Ranbaxy first quarter net sales surges 65 per cent
By New Statesman - 12 May 11:45

Company reports net sales of $542m.

A5 Labs to acquire assets and technology from Vida Pharma
By New Statesman - 10 May 12:58

The all share transaction is expected to close on or before June 15.

Merck & Co sales doubles in first quarter
By New Statesman - 06 May 11:41

Company posts net income of $330.2m.

King Pharma, Acura plan new drug applicaion for Acurox tablets
By New Statesman - 04 May 12:24

The companies expect to submit in early 2011.

FDA approval for Dendreon Provenge immunotherapy vaccine
By New Statesman - 03 May 11:55

Nasdaq-listed company Dendreon has received approval from the US Food and Drugs Agency (FDA) to comm

Pages